Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Superior Laryngeal Nerve BlockSedationDexmedetomidineAwake Fiberoptic IntubationHemimandibulectomyAnticipated Difficult Airway
Interventions
DRUG

Dexmedetomidine

The patients were given 0.5 mcg /kg dexmedetomidine over 10 min via syringe pump, followed by 0.2-0.7 mcg/kg/hour until the end of intubation according to hemodynamics.

DRUG

Superior laryngeal nerve block

The patients received an airway nerve block through bilateral superior laryngeal nerve block and trans-tracheal injection for recurrent laryngeal nerve.

Trial Locations (1)

11796

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06651905 - Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation. | Biotech Hunter | Biotech Hunter